✦ LIBER ✦

Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil and calcium folinate in stage II–III gastric cancer

✍ Scribed by E. Topuz; F.N. Aykan; M. Basaran; K. Uygun; F. Tas; B. Sakar; P. Saip; D. Bugra; H. Camlica; A. Aydiner

Book ID: 117667527
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 329 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)80983-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nuclear Maspin expression is associated

Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer

✍ Wolfgang Dietmaier; Marcus Bettstetter; Peter J. Wild; Matthias Woenckhaus; Petr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 528 KB

## Abstract Maspin, a member of the Serpin protease inhibitor family, is overexpressed in poorly differentiated colorectal tumors and more frequently found in tumors with microsatellite instability. Immunohistochemical nuclear Maspin staining is predominantly seen in tumor cells at the invasion fro

Sequential chemotherapy with dose-dense

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial

✍ Matteo Dalla Chiesa; Gianluca Tomasello; Sebastiano Buti; Rodrigo Kraft Rovere; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 277 KB

Adjuvant chemotherapy with Cis-diamminod

Adjuvant chemotherapy with Cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck

✍ David A. Decker; Anibal Drelichman; John Jacobs; Judith Hoschner; Jeannie Kinzie 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

Gene-expression signature of tumor recur

Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5′fluoruracil-based adjuvant chemotherapy

✍ María Dolores Giráldez; Juan José Lozano; Míriam Cuatrecasas; Virginia Alonso-Es 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 245 KB

Biomarker analysis in stage III–IV (M0)

Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival

✍ Kim, J-S; Kim, M-A; Kim, T M; Lee, S-H; Kim, D-W; Im, S-A; Kim, T-Y; Kim, W H; Y 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 280 KB

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB